Gouynou, C. ., Pouillon, L. ., Rousseau, H. ., Zallot, C. ., Baumann, C. ., & Peyrin-Biroulet, L. . (2018). Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation. Gut. https://doi.org/10.1136/gutjnl-2017-315766 (Original work published 2018)